Rare early onset lower urinary tract disorders
罕见的早发性下尿路疾病
基本信息
- 批准号:MR/Y008340/1
- 负责人:
- 金额:$ 146.89万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The problem.Many children in the UK suffer with significant bladder problems that result in bed-wetting, incontinence, urine infections and even severe kidney damage. In fact, rare bladder conditions are the commonest cause of kidney failure in children who can only be kept alive by dialysis and transplantation. Up to one in three children with severe bladder emptying problems also have constipation. Bowel and bladder problems have more impact than almost any other medical condition on children's self-esteem, education and social relationships.Our approach to the problem.Genes are the inherited instructions in our cells providing the information for how our bodies develop. We know that many genes are important in how the bladder and ureters (tubes connected to the kidneys) develop and work. We have discovered changes in a number of these genes in children with rare severe bladder problems. However, we have collected samples and clinical information from many children where we still do not have a genetic answer. This represents a significant unmet need. Through this rare disease node we will create a network of clinicians and researchers across the UK to collect samples and information from children affected by these conditions creating a registry of affected individuals and genetic samples for further study. We will work as a collaborative team to address these challenging problems and train and support the next generation of researchers and clinicians to care for affected families.We propose three answers: 1. to use new types of genetic analysis, where we can study structural changes in the genetic material in a cell, to find the causes of severe inherited bladder problems; 2. to look at how genes are switched on and off in the bladder and ureters in children with a severe condition called bladder exstrophy from samples taken at surgery and compare these patterns to healthy children. This will give us an insight into how the organs develop and how and why this may go wrong; and 3. we will look at new exciting ways to deliver genes to the body so that they may correct these conditions using an approach called gene therapy.Finding the responsible genes will allow us to: 1. give families the reason for their children's problems; 2. do simple genetic tests on other family members to see if they may require check-ups to detect and prevent the progression to severe bladder and kidney disease; and 3. start to understand the reasons that children are affected by these problems which will help to develop novel treatments. Furthermore, understanding rare inherited types of bladder problems can provide reasons as to why children have more common problems like bed-wetting and urine infections, which affect nearly one million UK children.We will organise meetings with affected families to discuss our work and seek input to guide the way that we approach these studies and share information about them through charities like ERIC, the Children's Bowel and Bladder Charity. The 2018 NHS England guidance on Excellence in Continence Care highlights the inequalities and need for improvements in clinical care for individuals with urinary and bowel incontinence.Because severe inherited bladder disorders can affect multiple family members their impact is greater. As most are inherited in an 'autosomal recessive' pattern (a genetic change inherited from each unaffected parent), these conditions are more common in communities where marriage within families occurs. In the UK there is a significant burden in families of Pakistani origin. In the Health Profile for England Report 2017, there was a threefold increased infant mortality in British Pakistanis and other measures of poorer health in this community. Therefore, supporting research in these disorders will have a major health benefit in a disadvantaged community.
问题:在英国,许多儿童患有严重的膀胱问题,导致尿床、尿失禁、尿液感染,甚至严重的肾损伤。事实上,罕见的膀胱疾病是儿童肾衰竭的最常见原因,他们只能通过透析和移植来维持生命。多达三分之一的患有严重膀胱排空问题的儿童也有便秘。肠道和膀胱问题对儿童的自尊、教育和社会关系的影响几乎比任何其他医疗条件都要大。我们解决问题的方法基因是我们细胞中的遗传指令,为我们的身体如何发育提供信息。我们知道许多基因对膀胱和输尿管(连接肾脏的管道)的发育和工作都很重要。我们发现患有罕见严重膀胱问题的儿童中许多基因发生了变化。然而,我们已经从许多儿童那里收集了样本和临床信息,我们仍然没有遗传答案。这是一个未得到满足的重大需求。通过这个罕见疾病节点,我们将在英国各地建立一个临床医生和研究人员网络,收集受这些疾病影响的儿童的样本和信息,为进一步研究建立受影响个体和遗传样本的登记册。我们将作为一个合作团队来解决这些具有挑战性的问题,并培训和支持下一代研究人员和临床医生照顾受影响的家庭。使用新型遗传分析,我们可以研究细胞遗传物质的结构变化,以找到严重遗传性膀胱问题的原因; 2.从手术中采集的样本中观察患有严重膀胱外翻的儿童的膀胱和输尿管中基因是如何开启和关闭的,并将这些模式与健康儿童进行比较。这将使我们深入了解器官如何发育,以及如何以及为什么会出错; 3.我们将寻找新的令人兴奋的方法来将基因传递到身体,这样他们就可以使用一种叫做基因治疗的方法来纠正这些状况。2找到负责的基因将使我们能够:1。让家庭了解孩子问题的原因; 2.对其他家庭成员进行简单的基因测试,看看他们是否需要检查,以发现和防止发展为严重的膀胱和肾脏疾病;以及3.开始了解儿童受这些问题影响的原因,这将有助于开发新的治疗方法。此外,了解罕见的遗传性膀胱问题可以解释为什么儿童会出现尿床和尿液感染等更常见的问题,这些问题影响着近一百万英国儿童。我们将组织与受影响家庭的会议,讨论我们的工作并寻求意见,以指导我们处理这些研究的方式,并通过ERIC、儿童肠道和膀胱慈善机构等慈善机构分享有关它们的信息。2018年英国国民保健署(NHS)关于失禁护理的卓越指南强调了对尿失禁和肠失禁患者临床护理的不平等和改善需求。由于严重的遗传性膀胱疾病可能影响多个家庭成员,因此其影响更大。由于大多数是以“常染色体隐性”模式遗传的(从每个未受影响的父母遗传的遗传变化),这些情况在家庭内部婚姻发生的社区中更常见。在英国,巴基斯坦裔家庭的负担很重。在2017年英格兰健康状况报告中,英国巴基斯坦人的婴儿死亡率增加了三倍,该社区的其他健康状况较差。因此,支持这些疾病的研究将在弱势群体中产生重大的健康益处。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human HPSE2 gene transfer ameliorates bladder pathophysiology in a mutant mouse model of urofacial syndrome
人类 HPSE2 基因转移改善尿面综合征突变小鼠模型的膀胱病理生理学
- DOI:10.7554/elife.91828.1
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Lopes F
- 通讯作者:Lopes F
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Newman其他文献
Clinical profile and treatment outcomes following laser monotherapy and combination therapy with bevacizumab in paediatric Coats disease (PCD)
- DOI:
10.1016/j.jaapos.2019.08.196 - 发表时间:
2019-08-01 - 期刊:
- 影响因子:
- 作者:
Vinod Sharma;Bhamy Hariprasad Shenoy;Jane Ashworth;William Newman;Susmito Biswas - 通讯作者:
Susmito Biswas
An experimental demonstration of avoided crossings with masses on springs
避免与弹簧上的质量交叉的实验演示
- DOI:
10.1119/1.5036752 - 发表时间:
2018 - 期刊:
- 影响因子:0.9
- 作者:
A. Lockhart;Alexandria Skinner;William Newman;Daniel B. Steinwachs;Shawn A. Hilbert - 通讯作者:
Shawn A. Hilbert
Real-world outcomes of Voretigene Neparvovec: a single-centre consecutive case series
沃瑞替尼(Voretigene Neparvovec)的真实世界结果:单中心连续病例系列
- DOI:
10.1038/s41433-025-03637-0 - 发表时间:
2025-02-03 - 期刊:
- 影响因子:3.200
- 作者:
Assad Jalil;Mariantonia Ferrara;Myrta Lippera;Neil Parry;Graeme C. Black;Sandra Banderas;Jane Ashworth;Sus Biswas;Georgina Hall;Jane Gray;William Newman;Tsveta Ivanova - 通讯作者:
Tsveta Ivanova
Hybrid world object tracking for a virtual teaching agent
虚拟教学代理的混合世界对象跟踪
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
William Newman;David Franzel;Takeshi Matsumoto;Richard Leibbrandt;T. Lewis;Martin H. Luerssen;D. Powers - 通讯作者:
D. Powers
The place of curettage in the diagnosis of carcinoma of the endometrium
- DOI:
10.1016/s0002-9378(15)33394-9 - 发表时间:
1968-03-01 - 期刊:
- 影响因子:
- 作者:
Robert H. Barter;Gloria Brennan;William Newman;Keith W. Merrill - 通讯作者:
Keith W. Merrill
William Newman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Newman', 18)}}的其他基金
Standard Research Grant: A Complete Digital Edition of Newton’s Chymical Corpus
标准研究补助金:牛顿化学语料库的完整数字版
- 批准号:
2240879 - 财政年份:2023
- 资助金额:
$ 146.89万 - 项目类别:
Continuing Grant
Integrating CRISPR-Cas Technology into Organic Electronics for Rapid Point-of-Care Genotyping
将 CRISPR-Cas 技术集成到有机电子器件中以实现快速护理点基因分型
- 批准号:
BB/X003442/1 - 财政年份:2023
- 资助金额:
$ 146.89万 - 项目类别:
Research Grant
Pleiotropic disorders of mitochondrial translation
线粒体翻译的多效性障碍
- 批准号:
MR/W019027/1 - 财政年份:2022
- 资助金额:
$ 146.89万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Roger Bacon's Pharmacology and the Prolongation of Life
博士论文研究:罗杰·培根的药理学与延长生命
- 批准号:
2043555 - 财政年份:2021
- 资助金额:
$ 146.89万 - 项目类别:
Standard Grant
A Multidimensional Reconstruction of the Order of Composition of Historical Manuscripts from Textual and Material Evidence
从文本和实物证据多维重构历史手稿的编排顺序
- 批准号:
2021012 - 财政年份:2020
- 资助金额:
$ 146.89万 - 项目类别:
Standard Grant
Multidimensional Chronological Analysis of Manuscript Corpora Using Isaac Newton's Chymical Papers as a Test Platform
以艾萨克·牛顿化学论文为测试平台的手稿语料库的多维年代分析
- 批准号:
1556864 - 财政年份:2016
- 资助金额:
$ 146.89万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Bringing Chemistry into Shape: the Chymico-Medical Arts in Early-Modern Germany
博士论文研究:将化学付诸实践:早期现代德国的化学医学艺术
- 批准号:
1026952 - 财政年份:2010
- 资助金额:
$ 146.89万 - 项目类别:
Standard Grant
Chymistry of Isaac Newton: A Rigorous Analysis of the Language of Alchemy
艾萨克·牛顿的化学:对炼金术语言的严格分析
- 批准号:
0924983 - 财政年份:2009
- 资助金额:
$ 146.89万 - 项目类别:
Standard Grant
Doctoral Dissertation Research: Magic and the Mechanics of the Unseen in the Medieval Natural Philosophy of William of Auvergne, Bishop of Paris (c.1190-1249).
博士论文研究:巴黎主教奥弗涅的威廉(c.1190-1249)中世纪自然哲学中的魔法和看不见的力学。
- 批准号:
0823395 - 财政年份:2009
- 资助金额:
$ 146.89万 - 项目类别:
Standard Grant
相似国自然基金
Crocin 抑制 Hartley 豚鼠早期骨关节炎发生的
作用机制研究
- 批准号:TGD24H060003
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
- 批准号:82372167
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
- 批准号:82372089
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
- 批准号:82371605
- 批准年份:2023
- 资助金额:46.00 万元
- 项目类别:面上项目
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
- 批准号:82371668
- 批准年份:2023
- 资助金额:52.00 万元
- 项目类别:面上项目
BNIP-2调控E-cadherin细胞内分选运输的机制研究
- 批准号:32100540
- 批准年份:2021
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
玉米Edk1(Early delayed kernel 1)基因的克隆及其在胚乳早期发育中的功能研究
- 批准号:31871625
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
膀胱癌高表达基因UPK3A的筛选、鉴定和相关研究
- 批准号:81101922
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
精神创伤相关的抑郁症HPA轴功能与相关脑区磁共振特征研究
- 批准号:81171286
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
早年心理应激对大鼠抑郁样行为及突触可塑性的影响
- 批准号:81171284
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)
ADA2 诊断平台:用于测定患者酶水平的即时检测,以诊断罕见疾病脱氨酶 2 缺乏症 (DADA2)
- 批准号:
10698520 - 财政年份:2023
- 资助金额:
$ 146.89万 - 项目类别:
Elucidating the causes and consequences of sleep disturbances in children with rare genetic syndromes
阐明罕见遗传综合征儿童睡眠障碍的原因和后果
- 批准号:
10693335 - 财政年份:2022
- 资助金额:
$ 146.89万 - 项目类别:
Integrative data science approaches for rare disease discovery in health records
用于发现健康记录中罕见疾病的综合数据科学方法
- 批准号:
10626148 - 财政年份:2022
- 资助金额:
$ 146.89万 - 项目类别:
Integrative data science approaches for rare disease discovery in health records
用于发现健康记录中罕见疾病的综合数据科学方法
- 批准号:
10541283 - 财政年份:2022
- 资助金额:
$ 146.89万 - 项目类别:
Elucidating the causes and consequences of sleep disturbances in children with rare genetic syndromes
阐明罕见遗传综合征儿童睡眠障碍的原因和后果
- 批准号:
10527175 - 财政年份:2022
- 资助金额:
$ 146.89万 - 项目类别:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
临床前肺纤维化,一个合适的罕见疾病队列
- 批准号:
10514944 - 财政年份:2020
- 资助金额:
$ 146.89万 - 项目类别:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
临床前肺纤维化,一个合适的罕见疾病队列
- 批准号:
10219354 - 财政年份:2020
- 资助金额:
$ 146.89万 - 项目类别:
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
临床前肺纤维化,一个合适的罕见疾病队列
- 批准号:
10683293 - 财政年份:2020
- 资助金额:
$ 146.89万 - 项目类别: